IndiaTickerLatest filing: Updates - Bliss GVS Pharma Limited
ObservedCompany dossier
Bliss GVS Pharma
NSE:BLISSGVS · ISIN INE416D01022
- Close
- ₹456 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Bliss GVS Pharma
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹210.4 Cr · PAT ₹25.8 Cr.
Exchange XBRLLatest ownership: promoter group 35.01% and public 64.99% as of 30 Jun 2026.
Exchange XBRLLatest rating action: Bliss GVS Pharma Limited: Ratings placed on Watch with Developing Implications
Archived reportMaterial events
Open timeline →What changed recently
Observed
Source filing Updates - Bliss GVS Pharma Limited
NSE · exchange filing
Observed
Source filing Bliss GVS Pharma Ltd - 506197 - Pre-Offer Advertisement & Corrigendum to Detailed Public Statement
BSE · exchange filing
Observed
Source filing Resignation of Director/KMP/SMP - Bliss GVS Pharma Limited
NSE · exchange filing
Observed
Source filing Cessation - Bliss GVS Pharma Limited
NSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹210.4 Cr
- Profit after tax
- ₹25.8 Cr
- EPS
- ₹2.27
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 35.01%
- Public
- 64.99%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL